Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

A practical approach to problems of hypercalcaemia.

Davies JH.

Endocr Dev. 2009;16:93-114. doi: 10.1159/000223691. Epub 2009 Jun 3. Review.

PMID:
19494663
2.

Investigation and management of hypercalcaemia in children.

Davies JH, Shaw NJ.

Arch Dis Child. 2012 Jun;97(6):533-8. doi: 10.1136/archdischild-2011-301284. Epub 2012 Mar 23. Review.

PMID:
22447996
3.

The role of the extracellular calcium-sensing receptor in health and disease.

Raue F, Haag C, Schulze E, Frank-Raue K.

Exp Clin Endocrinol Diabetes. 2006 Sep;114(8):397-405. Review.

PMID:
17039419
4.

Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.

Walls J, Ratcliffe WA, Howell A, Bundred NJ.

Clin Endocrinol (Oxf). 1994 Oct;41(4):407-13.

PMID:
7955450
5.

[Determination of plasma parathyroid hormone in the differential diagnosis of hypercalcemias associated with malignant tumors].

Gasser AB, Burckhardt P.

Schweiz Med Wochenschr. 1978 Jul 8;108(27):1031-4. French.

PMID:
663597
6.

Direct and indirect assessment of the parathyroid hormone response to pamidronate therapy in Paget's disease of bone and hypercalcaemia of malignancy.

Fraser WD, Logue FC, Gallacher SJ, O'Reilly DS, Beastall GH, Ralston SH, Boyle IT.

Bone Miner. 1991 Feb;12(2):113-21.

PMID:
1849762
7.

Clinical and laboratory features of calcium-sensing receptor disorders: a systematic review.

Gunn IR, Gaffney D.

Ann Clin Biochem. 2004 Nov;41(Pt 6):441-58. Review.

PMID:
15588433
8.

The pathophysiology of primary hyperparathyroidism.

Brown EM.

J Bone Miner Res. 2002 Nov;17 Suppl 2:N24-9. Review.

PMID:
12412774
9.

Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.

Schweitzer DH, Hamdy NA, Frölich M, Zwinderman AH, Papapoulos SE.

Clin Endocrinol (Oxf). 1994 Aug;41(2):251-6.

PMID:
7923831
10.

Hypercalcaemia. What does it signify?

Evans RA.

Drugs. 1986 Jan;31(1):64-74.

PMID:
3940849
12.

Calcium metabolism & hypercalcemia in adults.

Lumachi F, Motta R, Cecchin D, Ave S, Camozzi V, Basso SM, Luisetto G.

Curr Med Chem. 2011;18(23):3529-36.

PMID:
21756230
13.

Disorders of calcium homeostasis.

Carmeliet G, Van Cromphaut S, Daci E, Maes C, Bouillon R.

Best Pract Res Clin Endocrinol Metab. 2003 Dec;17(4):529-46. Review.

PMID:
14687587
14.

An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor.

Chikatsu N, Fukumoto S, Suzawa M, Tanaka Y, Takeuchi Y, Takeda S, Tamura Y, Matsumoto T, Fujita T.

Clin Endocrinol (Oxf). 1999 Apr;50(4):537-43.

PMID:
10468915
15.

Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia.

Ward BK, Magno AL, Blitvich BJ, Rea AJ, Stuckey BG, Walsh JP, Ratajczak T.

Clin Endocrinol (Oxf). 2006 May;64(5):580-7.

PMID:
16649980
16.

Circulating vitamin D metabolites and hypercalcaemia of malignancy.

Ralston SH, Cowan RA, Robertson AG, Gardner MD, Boyle IT.

Acta Endocrinol (Copenh). 1984 Aug;106(4):556-63.

PMID:
6548074
17.
18.

The diagnosis and management of hypercalcaemia.

Koh LK.

Ann Acad Med Singapore. 2003 Jan;32(1):129-39. Review.

PMID:
12625112
19.

Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.

Blind E, Raue F, Götzmann J, Schmidt-Gayk H, Kohl B, Ziegler R.

Clin Endocrinol (Oxf). 1992 Sep;37(3):290-7.

PMID:
1424212
20.

Parathyroid hormone-related peptide and primary hyperparathyroidism.

Testini M, Gurrado A, Lissidini G, Piccinni G, Greco L, Basile F, Biondi A.

Front Biosci (Schol Ed). 2010 Jan 1;2:299-312. Review.

PMID:
20036948

Supplemental Content

Support Center